Extension Study of Zemaira® i.v. Administration in Subjects With Emphysema Due to alpha1-proteinase Inhibitor Deficiency.
Clinical trial NCT00670007 · COMPLETED
Trial details
- NCT number
- NCT00670007
- Sponsor
- CSL Behring
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2008-04-01
- Primary completion
- 2014-09-01
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.